P14.25 18F-fluordesoxyglucose positron emission tomography (FDG-PET/CT) the detection of the primary lesion and staging in brain metastasis (BM) patients with cancer of unknown primary site (CUPS)

Background: In 30% of patients with brain metastasis (BM), BM are the first clinical manifestation of systemic malignancy, referred to as BM from cancer of unknown primary site (BM-CUPS). The value of (18)F-fluordesoxyglucose positron emission tomography (FDG-PET)/CT in the work-up of BM-CUPS patien...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Neuro Oncol
Main Authors: Wolpert, F., Le Rhun, E., Berghoff, A., Rushing, E., Andratschke, N., Regli, L., Reyns, N., Kaufmann, P., Preusser, M., Weller, M.
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2017
Assuntos:
POSTER PRESENTATIONS
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5464281/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox036.410
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados